Luk Lucas Tien Wee - Net Worth and Insider Trading

Luk Lucas Tien Wee Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Luk Lucas Tien Wee owns 1 companies in total, including CytoMed Therapeutics Ltd (GDTC) .

Click here to see the complete history of Luk Lucas Tien Wee’s form 4 insider trades.

Insider Ownership Summary of Luk Lucas Tien Wee

Ticker Comapny Transaction Date Type of Owner
GDTC CytoMed Therapeutics Ltd 2023-03-31 director & Chief Clinical Officer

Luk Lucas Tien Wee Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Luk Lucas Tien Wee Ownership Network

Ownership Network List of Luk Lucas Tien Wee

No Data

Ownership Network Relation of Luk Lucas Tien Wee


Luk Lucas Tien Wee Owned Company Details

What does CytoMed Therapeutics Ltd do?

Who are the key executives at CytoMed Therapeutics Ltd?

Luk Lucas Tien Wee is the director & Chief Clinical Officer of CytoMed Therapeutics Ltd. Other key executives at CytoMed Therapeutics Ltd include director & 10 percent owner Chee Kong Choo , director & CSO and CMO Jieming Zeng , and 10 percent owner Shu Wang .

CytoMed Therapeutics Ltd (GDTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CytoMed Therapeutics Ltd (GDTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CytoMed Therapeutics Ltd (GDTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CytoMed Therapeutics Ltd (GDTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CytoMed Therapeutics Ltd Insider Transactions

No Available Data

Luk Lucas Tien Wee Mailing Address

Above is the net worth, insider trading, and ownership report for Luk Lucas Tien Wee. You might contact Luk Lucas Tien Wee via mailing address: 1 Commonwealth Lane #08-22, Singapore U0 149544.

Discussions on Luk Lucas Tien Wee

No discussions yet.